In our investigation into the active ingredients that may affect the expression of the prognostically significant gene BIRC5 in HCC, we referred to the CTD to identify herbal compounds that could potentially interact with BIRC5. This evidence concerns the gene BIRC5 and hepatocellular carcinoma.